IRPCM

Vision of the IRPCM chemotherapy group:

 

• Ascertain and reduce antimicrobial resistance levels in mollicutes to protect global human and animals for the future

• • Coordinating international agreed standards for MIC of mollicute species

  • mapping global resistance of mollicutes of human and veterinary importance

  • reducing unnecessary use of antimicrobials and promoting good stewardship

  • understanding the molecular mechanisms of resistance

  • evaluation of new and alternative agents

 

Current Goals:

 

• To standardize veterinary mycoplasma antimicrobial sensitivity testing, including control strains and methodology like it was done for human mycoplasmas.

 

• To continue work on molecular determinants of antimicrobial resistance:

• Identifying breakpoints

• Epidemiological surveillance

• Monitoring of antimicrobial resistance

• Development of the molecular assay to track antimicrobial resistance in the real-time

• Molecular typing of strains with different susceptibility

• Evaluation of new and alternative chemotherapeutic agents.